This latest Report from the Beckley Foundation Drug Policy Programme looks at the various attempts by governments and academic institutions to develop a methodology for assessing and measuring the level of drug related harm, in order to better understand the impact of illegal drug use on society, and of policies and programmes that aim to reduce that impact.
Methamphetamine is a dangerous drug that represents a substantial challenge to policy makers, health care professionals, social service providers and the law enforcement community.
'State of Siege provides an overview of drug trafficking and drug-related violence and corruption in Mexico and argues that the United States must share responsibility with Mexico for addressing these problems for two reasons.
A Reality-Based Approach to Teens and Drugs was written to provide parents with the tools needed to evaluate and discuss strategies for protecting their teenagers from drug abuse.
This Drugs & Conflict briefing focuses on opium elimination efforts and the controversy about involving military forces in anti-drugs operations in Afghanistan.
This report, prepared by the RAND Corporation for the House of Commons Select Committee on Science and Technology in the United Kingdom, presents the results of four case studies examining the evidence base for the classification of illegal drugs in the context of the 1971 Misuse of Drugs Act.
This briefing paper looks at the history of the use of psychoactive drugs in India, and particularly the use of Cannabis and Opium derivatives in religious and social rituals.
Based on two studies carried out in the cities of Buenos Aires and Montevideo and additional research in Brazil, this report examines the origin, characteristics and impact of the explosive increase in consumption of cocaine base paste and crack in urban areas.
The third briefing paper from IDPC is a response to the call of the European Commission for civil society organisations to express their views on the Commission's Green Paper on the Role of Civil Society in Drugs Policy in the European Union.